Valeritas Reports Preliminary Full Year and Fourth Quarter 2017 Revenue Results
08. Januar 2018 07:30 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin Delivery...
Valeritas CEO Appears on Fox Business Network’s Top Morning Show
19. Dezember 2017 09:09 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), the maker of V-Go®, the only daily insulin delivery device worn like a patch, announced today that CEO...
Valeritas to Ring the Nasdaq Stock Market Closing Bell on December 19th
18. Dezember 2017 10:28 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company focused on improving health and simplifying life for people with diabetes by...
Valeritas Reports Third Quarter 2017 Financial Results
08. November 2017 16:11 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), the maker of V-Go®, the only daily basal-bolus insulin delivery device worn like a patch, today announced...
Valeritas’ V-Go® Wearable Insulin Delivery Device, Combined with a Simplified Insulin Titration Algorithm, Demonstrates Significant Reductions in A1C and Insulin Requirements in Patients with Type 2 Diabetes
03. November 2017 07:30 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company focused on improving health and simplifying life for people with diabetes by...
Valeritas to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
26. Oktober 2017 07:30 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company focused on improving health and simplifying life for people with diabetes by...
Valeritas to Report Third Quarter 2017 Results November 8, 2017
25. Oktober 2017 07:30 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company focused on improving health and simplifying life for people with diabetes by...
Valeritas Wins Fourth Consecutive Cardinal Health Supply Chain Excellence Award
11. Oktober 2017 16:05 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Oct. 11, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX) announced today that it has been awarded a Cardinal Health Supply Chain Excellence Award for the fourth...
Valeritas Announces Common Stock Purchase Agreement by Institutional Investor, Aspire Capital Fund, LLC
22. September 2017 16:05 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Sept. 22, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that it has entered into a common stock purchase agreement (the "Agreement") with Aspire...
Valeritas to Present Results of the Prospective Pragmatic Multicenter Clinical Trial of V-Go® Wearable Insulin Delivery Device to the European Diabetes Community
05. September 2017 16:05 ET
|
Valeritas, Inc.
Study demonstrated Clinical Efficacy and Lower Total Daily Insulin Dose in Patients with Type 2 Diabetes Poster Presentation on September 13 during the European Association for the Study of Diabetes...